Impel NeuroPharma







Below $13 per share since announcing "Now Available" and our underwhelming Pharmacy Partner. If we put out one more press release we could possibly close the week under $12. Looks like our plan is working.
 






Stock will likely fall to single digits by end of coming week. Ask yourself what your option set price is AND is this really a the move I should have made? I’m currently negotiating to get my old job back.
 












Oh shut up and grow a pair. This almost always happens with an FDA approval. You ever hear of ‘sell the news’?
To the Tune of NY NY:

Still "Selling the New",
Stocks Dropping Today,
I'm glad to be a part of it,
Impel, Impel...

Closed at $9.81 today. Unprecedented: lost 60% of value since approval. Lifeboats are already overflowing with people leaving this sinking ship.
 






So glad i was rejected by the stupid DM

you did me a favor!!!LOL

I have a pennies jar , maybe i can buy a 100 share with the pennies I have in the jar!!!!
Instant Karma to the asshole DM
I was not a "fit" LOL Yes , I am not a loser so I am not a fit
Enjoy your worthless shares!!!! LOL
 












Company is dumb as fuck.

Expected to be in all the EMRs -Barely in any.

Can't talk to our specialty Pharmacies - while they try and help. Fucking stupid leaders.

Stupid fucking researchers. Research "how to sell"
 


















Stock closed at $9.51 today, losing another 3.94% value. No 401k and my stock looking like it will be underwater forever. My husband thinks I should get out now but I don't really want to go through another job search. The only thing cool about this job is my manager. The way he talks it seems like he feels he's in the same boat as me. What about Y'all?
 












Simple Formula:

Founder hires Big Pharma executive as Head of Commercial.

- Head of Commercial hires sales and market access leadership based on their own insecurities, bringing in less intelligent “yes men” who can be controlled and stoke the Executives’ ego.

- Market Access hired because they have a lot of contacts in the payer community, even though they have never been able to leverage these contacts to gain favorable payer status for any of their products and usually blame the sales teams for lack of product sales.

- Sales leadership is typically big pharma friends or former colleagues (loyalist and yes men) or relatively inexperienced “leaders” who are eager to please “puppies” to their master (VP or Head of Sales).

Founders and Scientists continue to buy the line of BS from the Presidents and VP of Commercial Leadership that they hire, unknowingly starting off with a “Big Pharma” culture instead of a Start-up culture. It’s easy to blame the Founders and Scientists for making this mistake but we all know they:

- Are arrogant and believe their medicine is so good that it will actually sell itself.

- Are awkward introverts in many instances and are easy to fool with a great line of BS.

- Are either 1) completely hands off from commercial and provide little oversight to ensure their company is going to be successful, or; 2) complete control freaks that micromanage every decision being made, not allowing any chance of creating a successful commercial culture of trust, transparency and teamwork that must take place in a start-up.

There are many reasons start-up continue to fail, even with phenomenal products. It has been very rare to find a successful start-up over the past couple of years AND YET THIS TREND CONTINUES.

SUCH A WASTE! Founders and Scientists who are looking to form a successful start-up commercial team - WAKE UP!!!!!!!
 












My docs keep reminding me of the following point when I present Trudhesh_t to them:

"DHE nasal spray (Migranal®), was approved in December 1997 as a noninjectable version of DHE to overcome the limitations of IV administration."

They ask if Trudhesh_t is Superior or just a different nasal device. I can only tell them we were not-inferior. I thought we'd have better data than what we have to sell with.
 












Docs are not even pretending to be interested in Trudhesa. They are being polite but thats it. Meanwhile, ALL the big Migraine players have dramatically increased their advertising and focus. The stock appears to be a reflection of these trends. What a cluster-#@ck.
 






I get that the entire market was down again today BUT Impel losing another 10% down to 8.33? Really? That tells me the market analysts are looking at the same data we are which shows MDs aren't interested in simply a new device with no additional benefit and no coverage. Looks like coal in the stocking this year:(
 






I get that the entire market was down again today BUT Impel losing another 10% down to 8.33? Really? That tells me the market analysts are looking at the same data we are which shows MDs aren't interested in simply a new device with no additional benefit and no coverage. Looks like coal in the stocking this year:(
Impel is a dumpster fire.
 






You clearly do not work here. Far from a dumpster fire. Sorry you didn’t get the position. Maybe if you would spend more time working and not posting fake news on this website, you would have gotten the position.